Issa J Dahabreh

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Topics

Electronic Health Record

Coronary Artery

Top Venues

European journal of epidemiology

Statistics in medicine

Biostatistics (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah E Robertson, Jon A Steingrimsson, Issa J Dahabreh
Cluster Randomized Trials Designed to Support Generalizable Inferences. Evaluation review (2024)
Jiabei Yang, Ann W Mwangi, Rami Kantor, Issa J Dahabreh, Monicah Nyambura, Allison Delong, Joseph W Hogan, Jon A Steingrimsson
Tree-based subgroup discovery using electronic health record data: heterogeneity of treatment effects for DTG-containing therapies. Biostatistics (Oxford, England) (2023)
Sarah E Robertson, Jon Arni Steingrimsson, Issa J Dahabreh
Regression-based estimation of heterogeneous treatment effects when extending inferences from a randomized trial to a target population. European journal of epidemiology (2023)
Issa J Dahabreh, James M Robins, Sebastien J-P A Haneuse, Iman Saeed, Sarah E Robertson, Elizabeth A Stuart, Miguel A Hernán
Sensitivity analysis using bias functions for studies extending inferences from a randomized trial to a target population. Statistics in medicine (2023)
Sarah E Robertson, Jon Arni Steingrimsson, Issa J Dahabreh
Regression-based estimation of heterogeneous treatment effects when extending inferences from a randomized trial to a target population. European journal of epidemiology 38 (2) (2023)
Issa J Dahabreh, James M Robins, Sebastien J-P A Haneuse, Iman Saeed, Sarah E Robertson, Elizabeth A Stuart, Miguel A Hernán
Sensitivity analysis using bias functions for studies extending inferences from a randomized trial to a target population. Statistics in medicine (2023)
Jon A Steingrimsson, David H Barker, Ruofan Bie, Issa J Dahabreh
Systematically missing data in causally interpretable meta-analysis. Biostatistics (Oxford, England) (2023)
Sarah E Robertson, Jon Arni Steingrimsson, Issa J Dahabreh
Regression-based estimation of heterogeneous treatment effects when extending inferences from a randomized trial to a target population. European journal of epidemiology 38 (2) (2023)
Sarah E Robertson, Jon Arni Steingrimsson, Issa J Dahabreh
Regression-based estimation of heterogeneous treatment effects when extending inferences from a randomized trial to a target population. European journal of epidemiology (2023)
Andrew S Oseran, Tianyu Sun, Rishi K Wadhera, Issa J Dahabreh, James A de Lemos, Sandeep R Das, Christine Rutan, Aarti H Asnani, Robert W Yeh, Dhruv S Kazi
Enriching the American Heart Association COVID-19 Cardiovascular Disease Registry Through Linkage With External Data Sources: Rationale and Design. Journal of the American Heart Association 11 (18) (2022)
Bing Li, Constantine Gatsonis, Issa J Dahabreh, Jon Arni Steingrimsson
Estimating the area under the ROC curve when transporting a prediction model to a target population. Biometrics (2022)
Issa J Dahabreh, Sarah E Robertson, Lucia C Petito, Miguel A Hernán, Jon Arni Steingrimsson
Efficient and robust methods for causally interpretable meta-analysis: Transporting inferences from multiple randomized trials to a target population. Biometrics (2022)
Rahul Aggarwal, Robert W Yeh, Issa J Dahabreh, Sarah E Robertson, Rishi K Wadhera
Medicare eligibility and healthcare access, affordability, and financial strain for low- and higher-income adults in the United States: A regression discontinuity analysis. PLoS medicine 19 (10) (2022)
Jiabei Yang, Issa J Dahabreh, Jon Arni Steingrimsson
Causal interaction trees: Finding subgroups with heterogeneous treatment effects in observational data. Biometrics (2021)
Bora Youn, Ira B Wilson, Vincent Mor, Nikolaos A Trikalinos, Issa J Dahabreh
Population-level changes in outcomes and Medicare cost following the introduction of new cancer therapies. Health services research 56 (3) (2021)
Bora Youn, Nikolaos A Trikalinos, Vincent Mor, Ira B Wilson, Issa J Dahabreh
Real-world use and survival outcomes of immune checkpoint inhibitors in older adults with non-small cell lung cancer. Cancer 126 (5) (2020)
Issa J Dahabreh, Sarah E Robertson, Jon Arni Steingrimsson, Elizabeth A Stuart, Miguel A Hernán
Extending inferences from a randomized trial to a new target population. Statistics in medicine 39 (14) (2020)